WHERE TO WATCH
Astrazeneca Could Restart U.S. Trial as Volunteer Dies in Brazil Trial
October 21, 2020
Dr. Daniel B. Fagbuyi, Obama Administration Public Health Biodefense expert and Emergency Physician, joined Cheddar to discuss the latest coronavirus vaccine news.
In Seismic Shift, Warner Bros. to Stream All 2021 Films
Dec 1, 2020
Moderna Seeks Approval In U.S. And Europe for COVID-19 Vaccine
Dr. Reynold Panettieri, Professor of medicine at the Robert Wood Johnson Medical School, breaks down the details of the Moderna trials, the logistical challenges that come with distributing a vaccine, and next steps for Pfizer and Moderna requesting COVID-19 vaccine authorization in Europe.
Nov 23, 2020
Stocks Jump on Another Positive Monday for Vaccines
Astrazeneca's vaccine candidate with Oxford University shows an average efficacy of 70 percent, while Moderna reported an estimated 94.5 percent. Pfizer and BioNTech now say theirs is 95 percent effective. Andrew Smith, chief investment strategist at Delos Capital Advisors, joined Cheddar to discuss.
Dec 1, 2020
CDC Meeting to Discuss Coronavirus Vaccine Priority Groups
John LaMattina, senior partner at PureTech Health and former president of Pfizer Global Research and Development, discusses the latest developments on a coronavirus vaccine and emergency approval.